Agreed. Whilst some are looking to the future with pessimism...

Agreed. Whilst some are looking to the future with pessimism based on the quarterly, it may be perhaps that DCB is changing tack and taking the approach of under-promising and (hopefully) over-delivering. It unfortunately feels like we've had the reverse for the last year or so at least, so a change in that regard may be a positive. Although it will take some getting used to for those expecting a continuous stream of "things to look forward to".

Another positive is that sentiment is obviously in the toilet, smaller retailers are continuing to exit, and we're hopefully clearing the decks with some significant 'bad' news - DT departure, (some) problematic pre-clinicals, ongoing AML EMD recruitment issues, etc. Yet the share price is still holding relatively well. If RAC can actually start kicking some goals and getting some good news out, we're in a good place for that to have a significant impact. That is still a big IF for the moment though...